These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29447219)

  • 1. Optimization of prophylaxis for hemophilia A.
    Herbert RD; Broderick CR; Barnes C; Billot L; Zhou A; Latimer J
    PLoS One; 2018; 13(2):e0192783. PubMed ID: 29447219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of traditional vs. Canadian tailored prophylaxis dosing of prophylactic factor infusions in children with haemophilia A and B in a single hemophilia treatment center.
    Dodd C; Watts RG
    Haemophilia; 2012 Jul; 18(4):561-7. PubMed ID: 22221939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels.
    Shapiro AD; Ragni MV; Kulkarni R; Oldenberg J; Srivastava A; Quon DV; Pasi KJ; Hanabusa H; Pabinger I; Mahlangu J; Fogarty P; Lillicrap D; Kulke S; Potts J; Neelakantan S; Nestorov I; Li S; Dumont JA; Jiang H; Brennan A; Pierce GF
    J Thromb Haemost; 2014 Nov; 12(11):1788-800. PubMed ID: 25196897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A.
    Young G; Mahlangu J; Kulkarni R; Nolan B; Liesner R; Pasi J; Barnes C; Neelakantan S; Gambino G; Cristiano LM; Pierce GF; Allen G
    J Thromb Haemost; 2015 Jun; 13(6):967-77. PubMed ID: 25912075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling to Predict Factor VIII Levels Associated with Zero Bleeds in Patients with Severe Hemophilia A Initiated on Tertiary Prophylaxis.
    Chowdary P; Fischer K; Collins PW; Cotterill A; Konkle BA; Blanchette V; Pipe SW; Berntorp E; Wolfsegger M; Engl W; Spotts G
    Thromb Haemost; 2020 May; 120(5):728-736. PubMed ID: 32369844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VIII half-life and clinical phenotype of severe hemophilia A.
    van Dijk K; van der Bom JG; Lenting PJ; de Groot PG; Mauser-Bunschoten EP; Roosendaal G; Grobbee DE; van den Berg HM
    Haematologica; 2005 Apr; 90(4):494-8. PubMed ID: 15820945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A history of prophylaxis in haemophilia.
    Moreno MM; Cuesta-Barriuso R
    Blood Coagul Fibrinolysis; 2019 Sep; 30(1S Suppl 1):S1-S3. PubMed ID: 31517707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian Forecasting Utilizing Bleeding Information to Support Dose Individualization of Factor VIII.
    Abrantes JA; Solms A; Garmann D; Nielsen EI; Jönsson S; Karlsson MO
    CPT Pharmacometrics Syst Pharmacol; 2019 Dec; 8(12):894-903. PubMed ID: 31668021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized prophylaxis.
    Collins PW
    Haemophilia; 2012 Jul; 18 Suppl 4():131-5. PubMed ID: 22726096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion requirements of adolescents with severe haemophilia A.
    Aronstam A; McLellan DS; Turk P
    J Clin Pathol; 1979 Sep; 32(9):927-30. PubMed ID: 512053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII half-life and intensity of treatment in hemophilic patients.
    Vicente V
    Haematologica; 2005 Apr; 90(4):437. PubMed ID: 15820932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailored versus standard dose prophylaxis in children with hemophilia A.
    Santoro C; Baldacci E; Mercanti C; Mazzucconi MG
    Semin Thromb Hemost; 2013 Oct; 39(7):711-22. PubMed ID: 24022808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of prophylactic treatment in patients with hemophilia.
    López Fernández MF
    Blood Coagul Fibrinolysis; 2019 Sep; 30(1S Suppl 1):S22-S24. PubMed ID: 31157677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, efficacy and pharmacokinetics of rVIII-SingleChain in children with severe hemophilia A: results of a multicenter clinical trial.
    Stasyshyn O; Djambas Khayat C; Iosava G; Ong J; Abdul Karim F; Fischer K; Veldman A; Blackman N; St Ledger K; Pabinger I
    J Thromb Haemost; 2017 Apr; 15(4):636-644. PubMed ID: 28166608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the outcomes of using longer-acting prophylactic factor VIII to treat people with severe hemophilia A: a hypothetical decision analysis.
    Miners AH; Krishnan S; Pasi KJ
    J Thromb Haemost; 2016 Nov; 14(11):2141-2147. PubMed ID: 27510890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes in hemophilia A patients undergoing tailoring of prophylaxis based on population-based pharmacokinetic dosing.
    Nagao A; Yeung CHT; Germini F; Suzuki T
    Thromb Res; 2019 Jan; 173():79-84. PubMed ID: 30496937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of individualized primary prophylactic treatment of 19 cases of children with severe hemophilia A].
    Liu GQ; Tang L; Wu XY; Zhen YZ; Li G; Chen ZP; Wang Y; Zhang NN; Zhang JS; Yu GX; Wu RH
    Zhonghua Er Ke Za Zhi; 2016 Dec; 54(12):923-926. PubMed ID: 27938593
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic use of factor VIII: an economic evaluation.
    Bohn RL; Avorn J; Glynn RJ; Choodnovskiy I; Haschemeyer R; Aledort LM
    Thromb Haemost; 1998 May; 79(5):932-7. PubMed ID: 9609224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study.
    Collins P; Faradji A; Morfini M; Enriquez MM; Schwartz L
    J Thromb Haemost; 2010 Jan; 8(1):83-9. PubMed ID: 19817995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.